Profit Or Loss [Abstract]

Hyloris Pharmaceuticals SA - Filing #5880974

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
8,458,000 EUR
2,087,000 EUR
Cost of sales
227,000 EUR
93,000 EUR
Profit (loss) from operating activities
7,130,000 EUR
15,993,000 EUR
Finance income
1,165,000 EUR
898,000 EUR
Finance costs
378,000 EUR
285,000 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method
81,000 EUR
147,000 EUR
Profit (loss) before tax
6,342,000 EUR
15,380,000 EUR
Tax expense (income)
- EUR
- EUR
Profit (loss)
6,342,000 EUR
15,380,000 EUR
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
6,342,000 EUR
15,380,000 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
0.23
0.55

Talk to a Data Expert

Have a question? We'll get back to you promptly.